Ventures Fund Iv Gene Flagship's Net Worth

Ventures Fund Iv Gene Flagship's net worth is estimated to be at least $141,170,689.97 as of 03/29/2024. CoreStreet's estimation of Ventures Fund Iv Gene Flagship's net worth is based on their sale of stock and current holding of stock.

Ventures Fund Iv Gene Flagship is Major Shareholder at Evelo Biosciences Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,411,255 units of EVLO stock on 07/11/2023. Their biggest sale was on 05/21/2020 when they sold 500,000 units of Moderna Inc stock for $33,445,000.00. They typically trade 1 times per year.

Total value of insider buys:
  • $100,012,494.69
Total value of insider sells:
  • $41,158,195.28
Most recent insider trade:
  • July 11, 2023

Ventures Fund Iv Gene Flagship's Insider Trading History

Evelo Biosciences IncTitleAmountPriceTypeTotal Value
July 11, 2023
Major Shareholder5,411,255$2.31Buy$12,499,999.05
May 27, 2022
Major Shareholder27,397,259$1.46Buy$39,999,998.14
Feb. 2, 2021
Major Shareholder130,000$15.00Buy$1,950,000.00
June 29, 2020
Major Shareholder4,666,666$3.75Buy$17,499,997.50
May 11, 2018
Major Shareholder281,250$16.00Buy$4,500,000.00
Rubius Therapeutics IncTitleAmountPriceTypeTotal Value
March 19, 2021
Major Shareholder210,000$29.00Buy$6,090,000.00
Kaleido Biosciences IncTitleAmountPriceTypeTotal Value
Feb. 8, 2021
Major Shareholder215,000$11.50Buy$2,472,500.00
June 4, 2020
Major Shareholder2,000,000$7.50Buy$15,000,000.00
Moderna IncTitleAmountPriceTypeTotal Value
May 21, 2020
Director500,000$66.89Sell$33,445,000.00
Dec. 11, 2019
Director238,301$18.65Sell$4,444,313.65
Dec. 9, 2019
Director172,137$18.99Sell$3,268,881.63